Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05861349
Other study ID # JagiellonianU71
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 1, 2023
Est. completion date May 3, 2024

Study information

Verified date May 2024
Source Jagiellonian University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this observational study is to test the new kind of ultrasound-based measurements in patients with carpal tunnel syndrome. The main questions it aims to answer are: - Do the measurements of the size of the median nerve at the point where it is maximally compressed accurately diagnose carpal tunnel syndrome? - May these measurements accurately tell how severe is the carpal tunnel syndrome? Participants will be asked to: - Undergo conduction studies of median and ulnar nerve. - Undergo ultrasound of the median nerve. - Fill out the Boston carpal tunnel questionnaire and a demographic questionnaire. Researchers will compare the group of patients with carpal tunnel syndrome with healthy volunteers to see if respective measurements differ significantly between groups.


Description:

Carpal tunnel syndrome (CTS) is the most common compression neuropathy. CTS results from the compression of the median nerve in the carpal tunnel. The main symptoms include pain and other unpleasant sensations in hand and wrist. In more advanced stage, weakness and wasting of the thenar and other muscles innervated by median nerve occurs, which may lead to permanent impairment of manual performance. Nerve conduction studies (NCS) remain the method of choice in diagnosing CTS. However ultrasonography (US) is increasingly used along with or instead of NCS. Most frequently, the increase of the cross-sectional area of the median nerve at the inlet to the carpal tunnel is regarded as the marker of CTS. A number of other measurements such as median nerve mobility, volar bulging of flexor retinaculum and others were also studied to increase diagnostic sensitivity and specificity. In this study the investigators aim to assess the utility of measurements made at the point of the maximal stenosis of the median nerve in the tunnel to diagnose CTS. So far, there were only few studies, which visualized the maximal nerve stenosis, which is the essential pathological feature of CTS. In general, the group of patients with CTS and controls will undergo NCS of symptomatic median and ipsilateral ulnar nerves and US of the symptomatic median nerve with measurements of the cross-sectional area, diameter and echogenicity at various points, including the point of the maximal stenosis. The location of the maximal stenosis with respect to external (distal crease) and internal (wrist and hand bones and thenar musculature) will also be evaluated. Subjects will also be asked to fill out the Boston Carpal Tunnel Questionnaire (BCTQ) and a demographic questionnaire. US measurements will be compared between patients and healthy volunteers. US measurements, especially those made at the point of stenosis will be correlated among patients with clinical severity of CTS, reflected by the score in BCTQ and with the grade of electrophysiological severity as introduced by Padua et al. [1].


Recruitment information / eligibility

Status Completed
Enrollment 84
Est. completion date May 3, 2024
Est. primary completion date February 29, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: - Symptoms of CTS - Electrophysiologic and/or ultrasonographic confirmation of CTS diagnosis Exclusion Criteria: - Psychiatric or cognitive conditions with may disturb participation in the study - Peripheral neuropathy in history - Fractures and severe trauma in the area of the wrist in history

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Nerve conduction study
Nerve conduction study of median and ulnar nerve together with sensory comparative methods on the affected side (sides).
Ultrasound
Ultrasound of the median nerve on the affected side (sides).

Locations

Country Name City State
Poland Jagiellonian University Medical College, Department of Neurology Kraków Lesser Poland

Sponsors (1)

Lead Sponsor Collaborator
Jakub Antczak

Country where clinical trial is conducted

Poland, 

References & Publications (1)

Padua L, LoMonaco M, Gregori B, Valente EM, Padua R, Tonali P. Neurophysiological classification and sensitivity in 500 carpal tunnel syndrome hands. Acta Neurol Scand. 1997 Oct;96(4):211-7. doi: 10.1111/j.1600-0404.1997.tb00271.x. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Difference in the diameter of median nerve in the site of its maximal compression Difference in the diameter of median nerve in the site of its maximal compression between patients with CTS and healthy controls. Through study completion, an average of 1 year.
Primary Difference in the cross-sectional area of median nerve in the site of its maximal compression Difference in the cross-sectional area of median nerve in the site of its maximal compression between patients with CTS and healthy controls. Through study completion, an average of 1 year.
Primary Difference in the echogenicity of median nerve in the site of its maximal compression Difference in the echogenicity of median nerve in the site of its maximal compression between patients with CTS and healthy controls. Through study completion, an average of 1 year.
Secondary Correlation of the diameter of median nerve in the site of its maximal compression with BCTQ score Correlation of the diameter of median nerve in the site of its maximal compression with BCTQ score in patients with CTS. Through study completion, an average of 1 year.
Secondary Correlation of the cross-sectional area of median nerve in the site of its maximal compression with BCTQ score Correlation of the cross-sectional area of median nerve in the site of its maximal compression with BCTQ score in patients with CTS. Through study completion, an average of 1 year.
Secondary Correlation of echogenicity of median nerve in the site of its maximal compression with BCTQ score Correlation of echogenicity of median nerve in the site of its maximal compression with BCTQ score in patients with CTS. Through study completion, an average of 1 year.
Secondary Correlation of the diameter of median nerve in the site of its maximal compression with CTS electrophysiological severity grade Correlation of the diameter of median nerve in the site of its maximal compression with CTS electrophysiological severity grade in patients with CTS. Through study completion, an average of 1 year.
Secondary Correlation of the cross-sectional area of median nerve in the site of its maximal compression with CTS electrophysiological severity grade Correlation of the cross-sectional area of median nerve in the site of its maximal compression with CTS electrophysiological severity grade in patients with CTS. Through study completion, an average of 1 year.
Secondary Correlation of echogenicity of median nerve in the site of its maximal compression with CTS electrophysiological severity grade Correlation of echogenicity of median nerve in the site of its maximal compression with CTS electrophysiological severity grade in patients with CTS. Through study completion, an average of 1 year.
See also
  Status Clinical Trial Phase
Completed NCT05067205 - Minimal Invasive Carpal Tunnel Release With the Novel Device N/A
Completed NCT03184688 - Platelet Rich Plasma for Carpal Tunnel Syndrome N/A
Completed NCT03582735 - Preoperative Neuromobilization Exercises for Individuals With Carpal Tunnel Syndrome N/A
Completed NCT05490420 - Effects of Upper Extremity Manual Lymphatic Drainage on Symptom Severity, Hand Functions, Electrophysiological and Ultrasonographic Measurements in Carpal Tunnel Syndrome N/A
Recruiting NCT05970692 - Cross-Cultural Adaptation and Psychometric Validation of the Turkish Version of Atroshi-Lyrén 6-item Symptoms Scale
Completed NCT04043780 - Clinical Validation of a Decompression Prototype Splint for Patients With Carpal Tunel Syndrome N/A
Completed NCT03880812 - Cost Information on Carpal Tunnel Syndrome Treatment Decisions N/A
Recruiting NCT05372393 - Carpal Tunnel Release Under Local Anaesthesia With or Without Distal Median Nerve Block N/A
Recruiting NCT05328180 - aDjunct bicarbonatE in Local anaesthesIa for CarpAl Tunnel rElease (DELICATE) N/A
Recruiting NCT05503719 - An Absorbable Suture Versus a Non-absorbable Suture in Carpal Tunnel Release, a Randomized Controlled Trial N/A
Recruiting NCT05466162 - Soft Tissue Massage Along With Mobilization Technique on Symptoms and Functional Status of Carpal Tunnel Syndrome N/A
Completed NCT04060875 - Research Protocol for Karuna Labs Inc.: Safety and Efficacy of Virtual Reality Graded Motor Imagery for Chronic Pain
Not yet recruiting NCT06294821 - 4AP to Delay Carpal Tunnel Release (CTR) Phase 2/Phase 3
Not yet recruiting NCT04328805 - Pain Reduction and Changes in Upper Limb Function Produced by an Ibuprofen Treatment in Carpal Tunnel Syndrome. Phase 4
Terminated NCT02791529 - Scalpel Versus Electrocautery for Surgical Skin Incision in Open Carpal Tunnel Release Phase 1
Completed NCT02141035 - Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome Phase 2/Phase 3
Completed NCT01887145 - Comparison of Long-term Outcomes Following Endoscopic or Open Surgery for Carpal Tunnel Syndrome N/A
Recruiting NCT01897272 - Post-Operative Splinting After Short-Incision Carpal Tunnel Release: a Prospective Study N/A
Completed NCT01394822 - Neuromuscular Ultrasound for Focal Neuropathies N/A
Enrolling by invitation NCT01017471 - Carpal Tunnel Syndrome Release Using PSU Retractor Phase 3